News from NYU Langone Health
Aspirin May Decrease Infection Rate After TJA Compared With Antithrombotic Therapy. (Healio)
(9/10) Results from the Musculoskeletal Infection Society Annual Meeting in Jersey City, N.J., indicated that aspirin use is linked to a reduced infection rate after total joint arthroplasty compared to non-aspirin antithrombotic therapy, which saw a decline in use from 97% to 19% in total hip arthroplasty and from 96% to 16% in total knee arthroplasty between 2013 and 2025; Vinay K. Aggarwal, MD, associate professor, Department of Orthopedic Surgery, and chief, adult reconstructive surgery service, said, “Not only by using aspirin are we making it easier for patients to administer medications for [venous thromboembolism] prophylaxis after hip and knee replacement, it is more tolerated, easier to administer and low cost; does not require insurance authorization and, more importantly, it is associated with lower infection and complication rates.”
‘No Such Thing As Too Young To Have Cancer’: NYU Langone Health On Early-Onset Trend. (Becker's Hospital Review)
(9/10) Mary L. Gemignani, MD, MPH, professor, Department of Surgery, chief, Division of Breast Surgery, highlights the institution’s investment in an Early Onset Cancer Program that focuses on four components: the adolescent and young adult component, breast, colon and gynecologic cancers, and notes the program “offers young folks a more comprehensive, holistic approach to their cancer.”
Meeting Patients Where They Are: How Health Systems Are Using Technology To Transform Care. (Becker's Hospital Review)
(9/10) During an August webinar hosted by Becker’s Healthcare and Wolters Kluwer, hospital leaders discussed how technology is transforming clinical workflows to address diverse patient and workforce needs, with Paul A. Testa, MD, assistant professor, the Ronald O. Perelman Department of Emergency Medicine, chief medical information officer, saying, “Technology for technology’s sake is no longer palpable,” adding, “If we can’t do it at scale, then what are we doing it for? I think scale and integration unto itself transcends really cool new tools, and that’s a discipline we’ve probably all learned through the years.”
The Potential Role Of Oral GLP-1s For Weight Management. (Medscape)
(9/10)* Pharmaceutical companies are advancing oral GLP-1 medications for weight management, while Karan R. Chhabra, MD, assistant professor, Departments of Surgery and Population Health, highlights bariatric surgery as an alternative and also comments on patients choosing between pens and oral GLP-1s, saying, “I don’t think it’s going to be one or the other, I think it’s going to be ‘both/and.’”
Maintaining Your Health While Aging. (Spectrum News)
(9/7) Nina Blachman, MD, associate professor, Department of Medicine, Division of Geriatric Medicine and Palliative Care, advises older adults to maintain vaccinations, including for COVID-19 and flu, despite conflicting state and federal guidance, emphasizing the importance of consulting physicians for personalized healthcare advice.
Affirmative Action Critics Refuse To Back Down In Fight Over Medical Bias Training. (KFF Health News)
(9/11) Cristina M. Gonzalez, MD, professor in the Department of Population Health and Department of Medicine, Division of General Internal Medicine and Clinical Innovation, designs and evaluates interventions to address clinicians’ prejudices, describing implicit-bias training as “a science”, noting that while finger-wagging and blaming in such training can make physicians defensive and lead them to avoid patients, when conducted correctly by experts, it is effective.
Also reporting is (9/11).
Blocked Blood Flow Makes Cancer Grow Faster. (Science Daily)
(9/11) A study from NYU Langone Health, published in JACC-CardioOncology, reveals that restricted blood flow can prematurely age bone marrow, weakening the immune system’s ability to combat cancer, as peripheral ischemia in leg arteries caused breast tumors in mice to grow at twice the rate compared to mice with normal blood flow; corresponding author Kathryn J. Moore, PhD, the Jean and David Blechman Professor of Cardiology, Department of Medicine, the Leon H. Division of Cardiology, and professor, Department of Cell Biology, said, “Our study shows that impaired blood flow drives cancer growth regardless of where it happens in the body,” and first author Alexandra Newman, PhD, a postdoctoral student in Moore’s lab, added, “Our results reveal a direct mechanism by which ischemia drives cancer growth, reprogramming stem cells in ways that resemble aging and promote immune tolerance.”
